These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4142804)

  • 1. [Action of the combination of hypothalamic phospholipids and megestrol acetate (IP 11) in prostatic hypertrophy. Results of a controlled clinical trial].
    Mazza G; Petracco S
    Minerva Urol; 1974; 26(6):293-300. PubMed ID: 4142804
    [No Abstract]   [Full Text] [Related]  

  • 2. Using antiandrogen therapy in benign prostatic hypertrophy.
    Geller J; Adler EH; Albert J; Brown DW; Licudan A; Manaig E
    Geriatrics; 1977 Apr; 32(4):63-7, 71. PubMed ID: 66171
    [No Abstract]   [Full Text] [Related]  

  • 3. Megestrol acetate in treatment of benign prostatic hypertrophy.
    Donkervoort T; Zinner NR; Sterling AM; Donker PJ; Van Ness J; Ritter RC
    Urology; 1975 Nov; 6(5):580-7. PubMed ID: 52933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Double-blind test on the therapeutic effects of a prostatic extract in the clinical syndrome of prostatic adenoma].
    Arduini M; Trucchi E
    Minerva Urol; 1972; 24(5):167-72. PubMed ID: 4141050
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gestagens--an effective conservative treatment of the so-called prostatic hypertrophy?].
    Reichelt H
    Wien Med Wochenschr; 1970 Nov; 120(45):792-5. PubMed ID: 4103896
    [No Abstract]   [Full Text] [Related]  

  • 6. A study of endocrine function in the treatment of benign prostatic hypertrophy with megestrol acetate.
    Lebech PE; Nordentoft EL
    Acta Obstet Gynecol Scand; 1967; 46(S9):25-38. PubMed ID: 4169449
    [No Abstract]   [Full Text] [Related]  

  • 7. [Raveron treatment of prostatic adenoma in the light of uroflowmetry (on the basis of 20 cases)].
    Janosz F; Zieliński J
    Pol Przegl Chir; 1975 Nov; 47(11A):1441-4. PubMed ID: 54910
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of megestrol acetate on uroflow rates in patients with benign prostatic hypertrophy: double-blind study.
    Geller J; Nelson CG; Albert JD; Pratt C
    Urology; 1979 Nov; 14(5):467-74. PubMed ID: 92091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumorous prostatic diseases. I. Prostatic adenoma--genesis, clinical aspects, therapy].
    Reichelt H
    Z Allgemeinmed; 1974 May; 50(15):688-93. PubMed ID: 4137484
    [No Abstract]   [Full Text] [Related]  

  • 10. [On drug therapy of prostatic hypertrophy].
    Rieben W
    Praxis; 1967 Jul; 56(30):1042-7. PubMed ID: 4180980
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urine flowmetry in patients with prostatic adenoma treated with Raveron].
    Steinmetz L; Adamkiewicz K
    Pol Przegl Chir; 1974 Oct; 46(10A):1375-82. PubMed ID: 4139698
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of urination disorders with Raveron].
    Ichim V
    Z Urol Nephrol; 1970 Apr; 63(4):255-60. PubMed ID: 4109019
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cerebral phospholipids and Parkinson's disease: cross-over double-blind study versus placebo].
    Casacchia M; Meco G; Corona R; Castellana F; Cusimano G
    Riv Neurol; 1981; 51(2):101-13. PubMed ID: 7017886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Conservative treatment of benign prostatic hyperplasia (author's transl)].
    Schoenenberger A; Hauri D
    Ther Umsch; 1982 Apr; 39(4):260-7. PubMed ID: 6179177
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medical treatment of prostatic adenoma. Urinary flow data].
    Giglio V; Campo B; Motta M
    Minerva Urol; 1972; 24(3):104-7. PubMed ID: 4141047
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of the effect of prostate extracts].
    Costa J; Guedes JM; Reis MO
    J Med (Oporto); 1965 Dec; 58(196):1024-7. PubMed ID: 4159123
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cerebral phospholipids in neuropsychiatry. Study of 100 cases].
    Feldmann H; Cretallaz JP
    Praxis; 1969 Nov; 58(46):1504-16. PubMed ID: 5395167
    [No Abstract]   [Full Text] [Related]  

  • 18. [1st results of clinical trials of a phospholipid complex from bovine brain in mental syndromes].
    Baruk H; Liteanu E; Liteanu D; Cretallaz JC; Lasalle M
    Ann Med Psychol (Paris); 1967 Dec; 2(5):788-96. PubMed ID: 5626309
    [No Abstract]   [Full Text] [Related]  

  • 19. Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trials.
    Buzdar AU; Smith R; Vogel C; Bonomi P; Keller AM; Favis G; Mulagha M; Cooper J
    Cancer; 1996 Jun; 77(12):2503-13. PubMed ID: 8640699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of benign prostatic hypertrophy with gestonorone caproate].
    Baranowska B; Kuzaka B
    Pol Tyg Lek; 1984 Jul 16-23; 39(29-30):999-1003. PubMed ID: 6209689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.